Corning Announces Lab for the Cure™ Program
08 Marzo 2010 - 2:30PM
Business Wire
Corning Incorporated (NYSE: GLW) today announced the Corning Lab
for the Cure™ program, a first-of-its-kind corporate sponsorship
agreement with Susan G. Komen for the Cure®. Under terms of the
agreement and through a one-time donation of $250,000, Corning Life
Sciences will engage with Susan G. Komen for the Cure throughout
2010 in co-marketing and co-branding initiatives to increase
awareness for Komen’s promise to save lives and find a cure for
breast cancer.
Susan G. Komen for the Cure is the largest funder of breast
cancer research outside of the U.S. government. Since 1983 the
organization has invested $400 million toward finding a cure, with
more than $230 million invested in research projects from 2006 to
2009.
“Susan G. Komen for the Cure is proud to welcome Corning Life
Sciences as a collaborator in its promise to end breast cancer
forever,” said Elizabeth Thompson, senior vice president, medical
and scientific affairs at Susan G. Komen for the Cure. “Every major
advance in breast cancer has been touched by a Komen grant and this
collaboration will allow us to continue funding ground-breaking
research and life-saving community outreach projects.”
The Corning Lab for the Cure program will provide Corning
customers in the U.S. and Canada with the opportunity to support
Susan G. Komen for the Cure through their everyday purchases of
select products. Corning Life Sciences products that are part of
the Corning Lab for the Cure program include the following:
- Costar® Pipettes
- Corning® 100 mm Dishes
- Corning Cell Scrapers
- Corning 50 mL Centrifuge
Tubes
- PYREX® Reusable Glass Media
Bottles
- Corning PES Filter Systems
- Corning® 150 mL Tube Top
Filters
As part of this program and beginning in the second quarter of
2010, Corning Life Sciences plans to make available special-edition
products which will feature pink caps and handles. These products
will include Corning Cell Scrapers, PYREX Reusable Glass Media
Bottles, and Corning 50 mL Centrifuge Tubes.
“We are pleased to be associated with an organization such as
Susan G. Komen for the Cure that, like Corning, places a high value
on the importance of advancing research and science,” said Kim
Titus, business development manager, Corning Life Sciences. “Susan
G. Komen for the Cure grants have helped make a significant impact
for researchers and scientists, including many who use our
products, in the fight against breast cancer. Our Corning Lab for
the Cure program is an ideal way to give back to the life science
industry and support a cause that touches people’s lives far beyond
the laboratory walls.”
Corning Life Sciences helps customers succeed by providing
innovative, high-quality products and services in the areas of
polymer science, biochemistry and molecular biology, glass melting
and forming, surface modification, and characterization science.
Corning cell-culture and assay labware products include
tissue-culture dishes; 6-, 12-, 24-, and 48-well cell-culture
plates; 96-, 384-, and 1536-well microplates; roller bottles;
flasks; tips; HYPERFlask® Vessels; and PCR Reaction Vessels. The
business’ dedication to quality, technology, and innovation has
enabled it to produce a comprehensive line of plastic laboratory
disposables and reusable glassware.
To learn more about or to order any Corning Life Sciences
products, please contact a customer service representative at
1-800-492-1110, toll free in the United States, (+1) 1-978-442-2200
internationally, or visit www.corning.com/lifesciences.
About Corning Incorporated
Corning Incorporated (www.corning.com) is the world leader in
specialty glass and ceramics. Drawing on more than 150 years of
materials science and process engineering knowledge, Corning
creates and makes keystone components that enable high-technology
systems for consumer electronics, mobile emissions control,
telecommunications and life sciences. Our products include glass
substrates for LCD televisions, computer monitors and laptops;
ceramic substrates and filters for mobile emission control systems;
optical fiber, cable, hardware & equipment for
telecommunications networks; optical biosensors for drug discovery;
and other advanced optics and specialty glass solutions for a
number of industries including semiconductor, aerospace, defense,
astronomy and metrology.
About Susan G. Komen for the Cure®
Nancy G. Brinker promised her dying sister, Susan G. Komen, she
would do everything in her power to end breast cancer forever. In
1982, that promise became Susan G. Komen for the Cure and launched
the global breast cancer movement. Today, Komen for the Cure is the
world’s largest grassroots network of breast cancer survivors and
activists fighting to save lives, empower people, ensure quality
care for all, and energize science to find the cures. Thanks to
events like the Komen Race for the Cure®, we have invested nearly
$1.5 billion to fulfill our promise, becoming the largest source of
nonprofit funds dedicated to the fight against breast cancer in the
world. For more information about Susan G. Komen for the Cure,
breast health, or breast cancer, visit komen.org or call 1-877 GO
KOMEN.
Grafico Azioni Corning (NYSE:GLW)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Corning (NYSE:GLW)
Storico
Da Lug 2023 a Lug 2024